Fingerprint
Dive into the research topics of 'Optimizing maturity and dose of iPSC-derived dopamine progenitor cell therapy for Parkinson’s disease'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Optimizing maturity and dose of iPSC-derived dopamine progenitor cell therapy for Parkinson’s disease
Benjamin M. Hiller, David J. Marmion, Cayla A. Thompson, Nathaniel A. Elliott, Howard Federoff, Patrik Brundin, Virginia B. Mattis, Christopher W. McMahon, Jeffrey H. Kordower
Research output: Contribution to journal › Article › peer-review
27
Scopus
citations